Hypoxia in cancer: significance and impact on clinical outcome
The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Hypoxia, a characteristic feature of locally advanced solid tumors, has emerged as a pivotal factor of the tumor (patho-)physiome since it can promote tumor progression and resistance to therapy. Hypoxia represents a "Janus face" in tumor biology because (a) it is associated with restrained proliferation, differentiation, necrosis or apoptosis, and (b) it can also lead to the development of an aggressive phenotype. Independent of standard prognostic factors, such as tumor stage and nodal status, hypoxia has been suggested as an adverse prognostic factor for patient outcome. Studies of tumor hypoxia involving the direct assessment of the oxygenation status have suggested worse disease-free survival for patients with hypoxic cervical cancers or soft tissue sarcomas. In head & neck cancers the studies suggest that hypoxia is prognostic for survival and local control. Technical limitations of the direct O(2) sensing technique have prompted the use of surrogate markers for tumor hypoxia, such as hypoxia-related endogenous proteins (e.g., HIF-1alpha, GLUT-1, CA IX) or exogenous bioreductive drugs. In many - albeit not in all - studies endogenous markers showed prognostic significance for patient outcome. The prognostic relevance of exogenous markers, however, appears to be limited. Noninvasive assessment of hypoxia using imaging techniques can be achieved with PET or SPECT detection of radiolabeled tracers or with MRI techniques (e.g., BOLD). Clinical experience with these methods regarding patient prognosis is so far only limited. In the clinical studies performed up until now, the lack of standardized treatment protocols, inconsistencies of the endpoints characterizing the oxygenation status and methodological differences (e.g., different immunohistochemical staining procedures) may compromise the power of the prognostic parameter used.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of intratumoral hypoxia is significantly associated with increased risk of treatment failure, invasion, metastasis, and patient mortality (3).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [3]
In the citing paper
“In early key findings, O 2 -sensitive microsensors were used to show that tumor hypoxia was associated with tumor progression (Vaupel & Mayer, 2007).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Vaupel & Mayer, 2007
In the citing paper
“Clinically, chronic elevation of HIF-1α is frequently detected in solid malignancies and is associated with angiogenic remodeling, aggressive disease progression, diminished therapeutic response, and poor clinical outcomes [248,249].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [248]
In the citing paper
“It has been estimated that 50 to 60% of solid tumors contain regions of hypoxia and/or anoxia”
From Hypoxic control of metastasis (2016) · cites this paper as [2]
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedTargeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
(1989) · PubMed · Cited by 3,343
Self-citationTumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Self-citationRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“For example, HIF-1! ES cells have been shown to have both higher apoptosis and proliferation rates [56] whereas higher proliferation was found to be combined with lower apoptosis in HIF-1"-deficient (a functional HIF-1 knockout) Hepa-1/c4 cells [57].”
BackgroundHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,926
Self-citationSmithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312
Research works printed but not linked: 2
- Vaupel, P., & Kelleher, D. K. (1999). Tumor hypoxia. Stuttgart: Wissenschaftliche Verlagsgesellschaft.
- Brizel, D. M. (1999). Human tumor oxygenation: The Duke University Medical Center experience. In P. Vaupel & D. K. Kelleher (Eds.), Tumor hypoxia (pp. 29–38). Stuttgart: Wissenschaftliche Verlagsgesellschaft.
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
“Hypoxia is a well-recognized tumor microenvironmental condition that is linked to poor patient outcome and resistance to therapies (Teicher, 1994; Liang, 1996; Semenza, 2004; Chi et al., 2006; Vaupel and Mayer, 2007; Sathornsumetee et al., 2008).”
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Targeting Tumor Microenvironment for Cancer Therapy
Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187
“In addition, the TME may experience two types of low oxygenation events, chronic and acute/cycling hypoxia [18,43].”
Background
Metadata
- Authors
- Vaupel, P., & Mayer, A.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Vaupel, Peter
- Venue
- Cancer and Metastasis Reviews
- Published
- 2007-04-18
- Volume
- 26
- Issue
- 2
- Pages
- 225-239
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2124496728
- Cited by
- 2,240
- References
- 145
- Citations by year
- 2026: 103 · 2025: 83 · 2024: 92 · 2023: 125 · 2022: 144 · 2021: 157 · 2020: 157 · 2019: 145 · 2018: 146 · 2017: 145 · 2016: 150 · 2015: 132 · 2014: 128 · 2013: 126 · 2012: 108
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer and Metastasis Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Krebshilfe
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- tumor hypoxia, prognostic factors, clinical outcomes, solid tumors, HIF-1α, GLUT1, CAIX, bioreductive drugs, oxygenation status, head and neck cancer, cervical cancer, soft tissue sarcoma, BOLD MRI, tumor progression, treatment resistance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Neoplasms, Prognosis, Cell Hypoxia, Treatment Outcome, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypoxia in cancer: significance and impact on clinical outcome. https://app.cochat.ai/papers/10.1007/s10555-007-9055-1
- The paper
- Vaupel, P., & Mayer, A. (2007). Hypoxia in cancer: significance and impact on clinical outcome. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-007-9055-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.